2008
DOI: 10.5649/jjphcs.34.433
|View full text |Cite
|
Sign up to set email alerts
|

Pharmaceutical Evaluation of Metronidazole Ointments for Cancerous Malodor Prepared in a Hospital

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…The subjects of this study were patients with a fungating tumor and malodor from infection, and other types of malodorous fungating tumors were not evaluated. In Japan, most studies have investigated the effects of topical MTZ on malodorous fungating tumors of breast cancer patients [ 5 , 8 , 13 – 29 ], but few investigated the efficacy and safety of topical MTZ on malodorous fungating wounds that are unrelated to breast cancer [ 30 34 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The subjects of this study were patients with a fungating tumor and malodor from infection, and other types of malodorous fungating tumors were not evaluated. In Japan, most studies have investigated the effects of topical MTZ on malodorous fungating tumors of breast cancer patients [ 5 , 8 , 13 – 29 ], but few investigated the efficacy and safety of topical MTZ on malodorous fungating wounds that are unrelated to breast cancer [ 30 34 ].…”
Section: Discussionmentioning
confidence: 99%
“…Topical MTZ has been approved and marketed for the treatment of malodorous fungating wounds only in the United Kingdom (UK). In Japan, where topical MTZ is yet to be approved, each medical institution prepares special topical MTZ formulations for patients with malodorous fungating tumors [ 5 , 8 , 9 ].…”
Section: Introductionmentioning
confidence: 99%